Systems Biology Opens New Research Pathways
Systems Biologists Are Attacking the Encrypted Messages That Would Allow Us to Predict and Change the Course of Disease
Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Prokarium is a biotechnology company with a vision to create the best platform for oral delivery of almost any recombinant protein vaccine. Its Vaxonella™ platform incorporates genetic and formulation technologies that are designed to optimize live bacterial vector-mediated antigen delivery: Spi-VEC, X-mark, ORT-VAC and BAR. Prokarium is based in Keele and London, UK.